Mergers and Acquisitions Archives

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

KYBORA announces that Megalabs has acquired acquired Fr!ska

February 3, 2023

Comments are off for this post.

Mergers and Acquisitions, News

KYBORA announces that Megalabs has acquired acquired Fr!ska

KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

KYBORA announces that Bayer Healthcare Pharmaceuticals has sold a PRV to argenx

November 23, 2020

Comments are off for this post.

Mergers and Acquisitions, News

KYBORA is pleased to announce that its client Bayer Healthcare Pharmaceuticals has sold a Priority Review Voucher (PRV) to argenx.

Recent blog post.

Antibody-Drug Conjugates

Posted: 4 days ago
KYBORA is Hiring! Healthcare Investment Banking Analyst

Posted: 1 week ago
Advancing Therapies for Inflammatory Diseases

Posted: 1 week ago
Advancing Rare and Orphan Drug Therapies

Posted: 2 weeks ago
Whitepaper: Japan Drug Loss

Posted: 3 weeks ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

Tell us about your business and corporate development needs.

Contact Us

KYBORA is a global advisory firm whose mission is to guide transformative healthcare companies to enduring success globally, by offering optimal M&A, licensing, fundraising and strategic advisory services in all key markets around the world.

About Us.

About KYBORA
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

Antibody-Drug Conjugates

Posted: 4 days ago
KYBORA is Hiring! Healthcare Investment Banking Analyst

Posted: 1 week ago

Terms of service | Privacy policy

Recent blog post.

Tags.

TYPE & ENTER: